Bioimpedance Measuring Devices

Bioimpedance Measuring Devices Market Outlook

As of 2023, the global bioimpedance measuring devices market is valued at approximately USD 2.5 billion, with a robust compound annual growth rate (CAGR) of around 8.2% anticipated from 2025 to 2035. This impressive growth can be attributed to several factors, including the increased prevalence of obesity and chronic diseases, growing awareness of personal health and fitness, and advancements in bioimpedance technology that allow for more accurate and non-invasive body composition assessment. Additionally, the rising demand for home healthcare solutions and remote monitoring technologies is further propelling market growth, emphasizing the need for user-friendly bioimpedance devices. As healthcare continues to integrate technology, bioimpedance devices are increasingly being utilized in both clinical and wellness settings, enhancing their market presence significantly.

Growth Factor of the Market

The bioimpedance measuring devices market is primarily driven by the growing emphasis on preventive healthcare, which encourages routine health monitoring. As individuals become more health-conscious, the demand for tools that facilitate regular tracking of health metrics such as body fat percentage, muscle mass, and fluid distribution has surged. Technological advancements have made bioimpedance devices more accessible and affordable, propelling their adoption among both healthcare professionals and consumers. Additionally, the integration of bioimpedance devices with mobile health applications is enhancing user experience and engagement, thus expanding the market. Increased investments in research and development within the healthcare technology sector are also contributing to innovative product introductions, further stimulating market growth. Moreover, the rising incidences of lifestyle-related diseases are creating a heightened need for effective health monitoring solutions across various demographic segments.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 8.2% from 2025 to 2035, driven by increased health consciousness among consumers.
• Technological advancements are leading to the development of more accurate and user-friendly devices.
• Bioimpedance analysis is gaining traction in both clinical and wellness applications, enhancing its market scope.
• There is a rising trend of integrating bioimpedance devices with mobile applications for real-time health monitoring.
• The increasing prevalence of obesity and chronic diseases is propelling the demand for bioimpedance measuring devices.

By Product Type

Bioimpedance Analyzers:

Bioimpedance analyzers are sophisticated devices that provide detailed assessments of body composition, including fat mass, lean mass, and water distribution. These devices are typically utilized in clinical settings for health assessments, as they offer precise data that can be crucial for diagnosing conditions such as obesity, malnutrition, and fluid imbalances. Their ability to deliver accurate and multi-dimensional analysis makes them a preferred choice among healthcare professionals. Additionally, innovations in bioimpedance analyzers, such as wireless connectivity and mobile app integration, enhance their usability and appeal, thereby contributing to market growth.

Bioimpedance Meters:

Bioimpedance meters are compact devices designed for personal use, allowing individuals to measure their body composition conveniently at home. These meters often utilize single-frequency technology and provide essential metrics such as body fat percentage and muscle mass. The consumer shift towards fitness and wellness has fueled demand for bioimpedance meters, as they enable users to monitor their health without the need for professional assistance. Their portability and ease of use make them increasingly popular among fitness enthusiasts and individuals seeking to maintain a healthy lifestyle.

Bioimpedance Monitors:

Bioimpedance monitors are specialized devices that track body composition changes over time, making them ideal for individuals undergoing weight management programs or athletes focused on improving performance. These monitors provide continuous feedback, allowing users to adjust their diet and exercise regimens based on real-time data. The increasing focus on body composition analysis in sports and fitness is driving the demand for bioimpedance monitors. They often come equipped with advanced features such as smartphone connectivity and personalized recommendations, enhancing their attractiveness to tech-savvy consumers.

Bioimpedance Scales:

Bioimpedance scales are widely used in homes and fitness settings for quick assessments of body composition. These scales are equipped with integrated bioimpedance technology that estimates body fat, muscle mass, and hydration levels. Their ease of use and accessibility make them a popular choice for consumers looking to track their health metrics without the need for complex devices. The growing trend of integrating smart technology into everyday products is also elevating the appeal of bioimpedance scales, as many models now incorporate app connectivity for seamless data tracking and analysis.

Bioimpedance Sensors:

Bioimpedance sensors are advanced devices utilized in various applications, including medical diagnostics and wearable technology. These sensors can be embedded into clothing, wearables, or other devices to provide continuous monitoring of body composition and other health metrics. Their versatility and ability to deliver real-time data make them highly valuable in both clinical and home settings. With the rise of personalized healthcare and the increasing focus on continuous health monitoring, bioimpedance sensors are poised for significant market growth, particularly in the wearable technology sector.

By Application

Fitness and Wellness:

In the fitness and wellness sector, bioimpedance measuring devices are increasingly used by individuals to monitor body composition and track fitness progress. These devices provide invaluable data that helps users set and achieve health goals, making them popular among fitness enthusiasts. As more people recognize the importance of maintaining optimal health through regular monitoring, the demand for bioimpedance devices in this segment is expected to grow significantly. Furthermore, the proliferation of health and fitness applications that sync with bioimpedance devices enhances user engagement and motivates individuals to adopt healthier lifestyles.

Medical Diagnosis:

Bioimpedance measuring devices play a pivotal role in medical diagnosis, providing healthcare professionals with essential data for assessing patients’ body composition. They are particularly useful in diagnosing conditions related to obesity, malnourishment, and fluid retention. The accuracy and non-invasive nature of bioimpedance analysis make it a preferred method for evaluating health status in clinical settings. As chronic diseases become more prevalent globally, the reliance on bioimpedance devices for accurate diagnosis and management of medical conditions is expected to increase, driving growth in this segment.

Body Composition Analysis:

Body composition analysis is a critical application of bioimpedance measuring devices, as it allows users to understand their body fat percentage, muscle mass, and overall health. This analysis is essential for both athletes looking to optimize performance and individuals seeking to improve their health. With the growing awareness of the implications of body composition on overall wellness, there is a surge in demand for bioimpedance devices that provide precise and reliable data for body composition analysis. This trend is likely to continue, as both the fitness and healthcare industries emphasize the importance of understanding body composition in achieving health goals.

Research and Clinical Trials:

Bioimpedance measuring devices are increasingly utilized in research and clinical trials to gather data on body composition and health metrics in diverse populations. Their non-invasive nature and ability to provide real-time data make them valuable tools in clinical research settings. Researchers rely on bioimpedance devices to assess the effectiveness of interventions, monitor changes over time, and gather insights into the relationship between body composition and various health outcomes. The growing emphasis on evidence-based practice in healthcare is likely to drive further adoption of bioimpedance devices in research applications.

Others:

This category encompasses various niche applications of bioimpedance measuring devices, including veterinary medicine, sports science, and rehabilitation. As the understanding of bioimpedance technology expands, its applications are likely to extend into new fields. For instance, veterinarians can utilize bioimpedance devices to monitor the health and body composition of animals, while sports scientists may employ these tools to analyze athlete performance. The diversification of applications is expected to create new opportunities for market growth, as innovations continue to emerge in this field.

By Distribution Channel

Online Retail:

The online retail segment for bioimpedance measuring devices has seen significant growth due to the increasing trend of e-commerce and changing consumer shopping habits. Online platforms provide consumers with access to a wide variety of products, competitive pricing, and convenient purchasing options. The ongoing digital transformation in the retail landscape enables manufacturers and retailers to reach a broader audience, resulting in a surge in sales through online channels. Additionally, the ease of comparing products and reading customer reviews online allows consumers to make informed purchasing decisions, further driving the demand for bioimpedance devices through online retail.

Offline Retail:

Despite the growth of online retail, offline retail channels continue to play a crucial role in the distribution of bioimpedance measuring devices. Physical stores enable consumers to explore and interact with products before making a purchase, which is essential for devices that require a certain level of technical understanding. Specialty health and fitness stores, as well as pharmacies and medical supply stores, are key players in this segment. These retail outlets often provide knowledgeable staff who can assist customers in selecting the right devices based on their specific health and fitness needs, fostering trust and customer satisfaction.

Specialty Stores:

Specialty stores, including those focused on health and wellness products, are pivotal in promoting and selling bioimpedance measuring devices. These stores typically carry a curated selection of high-quality products and often provide expert advice to customers regarding their use. The personalized service and specialized knowledge available at specialty stores can significantly enhance the customer experience, leading to increased sales. Additionally, these stores often engage in community outreach and educational initiatives that raise awareness about the benefits of bioimpedance technology, contributing to market growth.

Medical Institutions:

Medical institutions, including hospitals, clinics, and rehabilitation centers, represent a vital distribution channel for bioimpedance measuring devices. These establishments require reliable and precise devices for patient assessment and monitoring. The integration of bioimpedance technology into routine clinical practice enhances patient care by enabling healthcare providers to make informed decisions based on accurate body composition data. As the healthcare industry continues to prioritize the adoption of advanced technologies, the demand for bioimpedance devices in medical institutions will likely grow, further solidifying this channel's importance in the market.

By Technology

Single Frequency Bioimpedance Analysis:

Single frequency bioimpedance analysis is one of the most common techniques used in bioimpedance measuring devices. This technology applies a single frequency of current to the body, allowing for the measurement of resistance and reactance, which are indicative of body composition. While this method is less complex and more affordable, it may not provide the depth of information offered by other technologies. However, its simplicity and effectiveness in providing quick assessments of body fat and hydration make it a popular choice among consumer-grade devices and fitness enthusiasts.

Multiple Frequency Bioimpedance Analysis:

Multiple frequency bioimpedance analysis utilizes several frequencies of electrical current, offering a more comprehensive understanding of body composition compared to single frequency methods. This technology enhances the accuracy of measurements by accounting for the various electrical properties of different tissues in the body, which can provide critical insights into hydration levels and fat distribution. As healthcare professionals seek more detailed data for clinical assessments, the adoption of multiple frequency bioimpedance analysis is on the rise, particularly in medical and research applications.

Bioimpedance Spectroscopy:

Bioimpedance spectroscopy represents a sophisticated approach to body composition analysis, employing a wide range of frequencies to gather data on tissue properties. This technology allows for a detailed examination of fluid distribution and the composition of different body compartments, making it a powerful tool in clinical diagnostics and research settings. Bioimpedance spectroscopy is particularly valuable in monitoring patients with conditions that affect their body fluids, such as heart failure or renal disease. Its increasing recognition in the medical community is likely to drive further advancements and adoption in the market.

Bioimpedance Vector Analysis:

Bioimpedance vector analysis is an advanced measurement technique that provides insights into the phase angle and vector impedance of body tissues. This information is crucial in evaluating cellular health and understanding changes in body composition over time. The method’s ability to analyze multiple aspects of impedance data enhances its application in both clinical and research environments, facilitating a more comprehensive assessment of overall health. As the focus on personalized healthcare grows, the demand for bioimpedance vector analysis is expected to expand significantly within the bioimpedance devices market.

Segmental Bioimpedance Analysis:

Segmental bioimpedance analysis involves measuring body composition by dividing the body into different segments, such as arms, legs, and trunk. This technology provides detailed insights into the distribution of fat and muscle mass across various body parts, allowing for targeted assessments in fitness and rehabilitation settings. The growing interest in health and fitness, coupled with the increasing prevalence of obesity, drives the demand for segmental bioimpedance analysis devices. Their ability to offer localized data makes them particularly valuable for personal trainers and healthcare providers focused on tailored health interventions.

By Region

The bioimpedance measuring devices market exhibits significant regional variations, influenced by factors such as healthcare infrastructure, technological advancements, and consumer awareness. North America holds a substantial share of the market, primarily due to the high prevalence of obesity and chronic diseases, as well as the increasing adoption of advanced healthcare technologies. The region is expected to grow at a CAGR of 7.5% during the forecast period, driven by innovations in bioimpedance technology and the rising demand for home healthcare solutions. Additionally, the presence of major players in the bioimpedance devices industry in the United States further supports market growth in North America.

In Europe, the bioimpedance measuring devices market is also witnessing considerable growth, fueled by increasing awareness of health and wellness among consumers and the focus on preventive healthcare. The European market is characterized by a strong emphasis on research and development, leading to continuous advancements in bioimpedance technology. The Asia Pacific region is expected to experience the highest growth rate, with a projected CAGR of 9.5% due to the rising population, increasing disposable incomes, and growing health consciousness among consumers. The emerging markets in Asia Pacific present vast opportunities for manufacturers, as the demand for bioimpedance devices continues to rise in response to the increasing prevalence of lifestyle-related diseases.

Opportunities

The bioimpedance measuring devices market is poised to harness numerous opportunities driven by rising health awareness and technological advancements. One of the key opportunities lies in the integration of artificial intelligence and machine learning into bioimpedance devices, allowing for more sophisticated data analysis and personalized health recommendations. As consumers increasingly seek data-driven insights into their health, manufacturers that leverage AI capabilities can create devices that offer tailored feedback and actionable recommendations, thereby enhancing user engagement and satisfaction. Furthermore, the expansion of telehealth and remote patient monitoring services offers a fertile ground for bioimpedance devices, as healthcare providers look for effective tools to monitor patients outside traditional clinical settings.

Another promising opportunity resides in the development of multifunctional bioimpedance devices that cater to a broader range of needs. For instance, devices that combine bioimpedance analysis with features such as heart rate monitoring, activity tracking, and even sleep analysis are increasingly appealing to consumers. This trend toward multifunctionality aligns with the growing demand for holistic health solutions, as individuals seek comprehensive tools to manage their overall well-being. Furthermore, the expansion of e-commerce platforms and online retail channels provides manufacturers with the opportunity to reach a global audience, allowing for increased sales and market penetration, particularly in developing regions where access to healthcare technology is expanding.

Threats

Despite the favorable growth prospects for the bioimpedance measuring devices market, several threats could hinder progress. One primary concern is the increasing competition from alternative technologies, such as DEXA (Dual-Energy X-ray Absorptiometry) and MRI (Magnetic Resonance Imaging), which offer highly accurate body composition assessments but are also more expensive and less accessible. As consumers and healthcare providers weigh the benefits and limitations of various assessment methods, bioimpedance devices may face challenges in maintaining their market share amidst these competing technologies. Furthermore, the rapid pace of technological advancement necessitates continuous innovation; manufacturers that fail to keep up with market trends and consumer preferences may find it difficult to survive in a highly competitive landscape.

Additionally, regulatory challenges pose threats to the bioimpedance measuring devices market. Manufacturers must navigate complex regulatory environments in different regions, which can delay product launches and increase development costs. Ensuring compliance with safety and efficacy standards is crucial for gaining approval from regulatory bodies. Any missteps in this process can lead to significant financial losses and damage to brand reputation. Moreover, the potential for data privacy concerns surrounding the use of bioimpedance devices that collect personal health information could deter consumers from adopting these technologies, further challenging market growth.

Competitor Outlook

• InBody Co., Ltd.
• Tanita Corporation
• Omron Healthcare, Inc.
• seca GmbH & Co. KG
• AccuFitness, LLC
• Bodystat Ltd.
• Fitbit, Inc.
• BodyTrace, Inc.
• Withings S.A.
• Bioelectrical Impedance Analysis, Inc.
• KaradaScan
• HBI (Hydration Bioimpedance)
• Xitact AG
• Fresenius Medical Care AG & Co. KGaA
• RJL Systems, Inc.

The competitive landscape of the bioimpedance measuring devices market is characterized by a mix of established companies and emerging players, all vying for a share of this rapidly growing segment. Major companies are actively investing in research and development to enhance their product offerings and maintain technological leadership. For instance, companies like InBody Co., Ltd. and Tanita Corporation have developed advanced bioimpedance analyzers that cater to medical professionals and fitness enthusiasts alike. These companies leverage their strong brand reputation and extensive distribution networks to reach a diverse customer base, further solidifying their market position.

Additionally, newer entrants in the market are bringing innovative solutions to meet the evolving needs of consumers. Startups focused on developing smart bioimpedance devices that integrate with mobile applications and leverage cloud-based analytics are gaining traction. These companies are targeting tech-savvy consumers who seek seamless health monitoring solutions. Collaboration and partnerships between technology firms and healthcare providers are also becoming increasingly common, driving the development of cutting-edge bioimpedance technologies that enhance patient care and engagement.

Key players like Omron Healthcare, Inc. and seca GmbH & Co. KG are also expanding their product lines to include multifunctional bioimpedance devices, which offer integrated health monitoring features. Such innovations cater to the rising consumer demand for comprehensive health management tools that encompass various aspects of wellness. As competition intensifies, companies are likely to adopt aggressive marketing strategies and price adjustments to differentiate their products and capture market share among diverse customer segments.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Xitact AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 KaradaScan
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Fitbit, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Bodystat Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Withings S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 BodyTrace, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AccuFitness, LLC
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 InBody Co., Ltd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 RJL Systems, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Tanita Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 seca GmbH & Co. KG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Omron Healthcare, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 HBI (Hydration Bioimpedance)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fresenius Medical Care AG & Co. KGaA
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Bioelectrical Impedance Analysis, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bioimpedance Measuring Devices Market, By Technology
    • 6.1.1 Single Frequency Bioimpedance Analysis
    • 6.1.2 Multiple Frequency Bioimpedance Analysis
    • 6.1.3 Bioimpedance Spectroscopy
    • 6.1.4 Bioimpedance Vector Analysis
    • 6.1.5 Segmental Bioimpedance Analysis
  • 6.2 Bioimpedance Measuring Devices Market, By Application
    • 6.2.1 Fitness and Wellness
    • 6.2.2 Medical Diagnosis
    • 6.2.3 Body Composition Analysis
    • 6.2.4 Research and Clinical Trials
    • 6.2.5 Others
  • 6.3 Bioimpedance Measuring Devices Market, By Product Type
    • 6.3.1 Bioimpedance Analyzers
    • 6.3.2 Bioimpedance Meters
    • 6.3.3 Bioimpedance Monitors
    • 6.3.4 Bioimpedance Scales
    • 6.3.5 Bioimpedance Sensors
  • 6.4 Bioimpedance Measuring Devices Market, By Distribution Channel
    • 6.4.1 Online Retail
    • 6.4.2 Offline Retail
    • 6.4.3 Specialty Stores
    • 6.4.4 Medical Institutions

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bioimpedance Measuring Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bioimpedance Measuring Devices market is categorized based on

By Product Type

• Bioimpedance Analyzers
• Bioimpedance Meters
• Bioimpedance Monitors
• Bioimpedance Scales
• Bioimpedance Sensors

By Application

• Fitness and Wellness
• Medical Diagnosis
• Body Composition Analysis
• Research and Clinical Trials
• Others

By Distribution Channel

• Online Retail
• Offline Retail
• Specialty Stores
• Medical Institutions

By Technology

• Single Frequency Bioimpedance Analysis
• Multiple Frequency Bioimpedance Analysis
• Bioimpedance Spectroscopy
• Bioimpedance Vector Analysis
• Segmental Bioimpedance Analysis

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• InBody Co., Ltd.
• Tanita Corporation
• Omron Healthcare, Inc.
• seca GmbH & Co. KG
• AccuFitness, LLC
• Bodystat Ltd.
• Fitbit, Inc.
• BodyTrace, Inc.
• Withings S.A.
• Bioelectrical Impedance Analysis, Inc.
• KaradaScan
• HBI (Hydration Bioimpedance)
• Xitact AG
• Fresenius Medical Care AG & Co. KGaA
• RJL Systems, Inc.